Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Chronic Inflammatory Demyelinating Polyneuropathy
Interventions
DRUG

H.P. Acthar® Gel

Trial Locations (5)

38163

Wesley Neurology Group, Memphis

66160

University of Kansas Medical Center, Kansas City

85018

Phoenix Neurological Associates, Phoenix

90033

University of Southern California, Los Angeles

05405

University of Vermont, Burlington

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Mamatha Pasnoor, MD

OTHER

NCT02574962 - Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy | Biotech Hunter | Biotech Hunter